Atlanta, GA – Cancer Kicks announced making a $33,750 grant to The University of Texas M.D. Anderson Cancer Center to help elucidate the potential role for Pembrolizumab, a novel immunotherapy drug, in fighting cholangiocarcinoma. The pharmaceutical company Merck will fund the clinical trial, but Cancer Kicks’ grant will go specifically to help cover the costs […]